| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4480 | Rohitukine | Anti-cancer agent, acting through gastrin antagonism and H /K -ATPase inhibition, modulating apoptosis pathways, antidyslipidemic, antiadipogenic, gastroprotective, antifertility, and antileishmanial |
|
| DCC4481 | Ronifibrate | Lipid modifying agent; Antihyperlipidemic and antiarteriosclerotic |
|
| DCC4482 | Rooperol | Novel p38α kinase inhibitor; Antioxidant |
|
| DCC4483 | Ropizine | Allosteric modulator of dextromethorphan binding to high-affinity sigma receptors |
|
| DCC4484 | Ror Modulator I | The first potent inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt |
|
| DCC4485 | Rorgammat Agonist 8-074 | Novel potent and selective RORγt agonist, showing robust antitumor efficacy in syngeneic tumor models and improving the efficacy of anti‑PD‑1 in a murine lung cancer model |
|
| DCC4486 | Rorgammat Inhibitor I | Novel RORgammaT inhibitor |
|
| DCC4487 | Rorγt Agonist | Novel RORγt agonist |
|
| DCC4488 | Rorγt-inverse-agonist-1j | Novel potent RORγt inverse agonist |
|
| DCC4489 | Rosma-18-d6 | Novel potent and selective CB2 probe (Ki for CB2: 0.8 nM and >12000 selectivity over CB1) |
|
| DCC4490 | Ros-modulator-3b | Novel P2X3 antagonist |
|
| DCC4491 | Rostaporfin | Photosensitiser for the treatment of age-related macular degeneration |
|
| DCC4492 | Rovafovir | Novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor |
|
| DCC4493 | Rovafovir Etalafenamide | Prodrug of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148 |
|
| DCC4494 | Roxatidine Acetate | Specific and competitive H2 receptor antagonist |
|
| DCC4495 | Rp-001 Hydrochloride | Potent agonist of S1P1 receptors |
|
| DCC4496 | Rp-23618 | Novel non-peptidic RANTES antagonist |
|
| DCC4497 | Rp-3-161 | Novel stimulator of autophagy, inhibiting Mycobacterium tuberculosis survival in macrophages, and targeting Pik1 |
|
| DCC4498 | Rpw-24 | Novel stimulator of host immune defenses, Inducing the transcription of putative immune effectors in C. elegans |
|
| DCC4499 | Rs-0466 | Novel inhibitor of β-amyloid-induced cytotoxicity |
|
| DCC4500 | Rs-104966 | Selective collagenase inhibitor, inducing the conformational change in the side-chains of the S1 pocket of MMP-1 |
|
| DCC4501 | Rs23597-190 Hydrochloride | Potent and selective competitive antagonist of 5-HT4 receptors |
|
| DCC4502 | Rs-25344 Featured | Selective phosphodiesterase-4 (PDE4) inhibitor |
|
| DCC4503 | Rs-8359 | Selective and reversible Monoamine_oxidase_A>monoamine oxidase A (MAO-A) inhibitor |
|
| DCC4504 | Rsr-056 | Specific ligand to CB2-positive spleen tissue of rats and mice |
|
| DCC4505 | rsva314 | Potent indirect activator of AMPK |
|
| DCC4506 | Rta-1701 | Novel allosteric RORγt inverse agonist |
|
| DCC4507 | Rti-371 | Selective inhibitor of the dopamine transporter (DAT), blocking cocaine-induced locomotor stimulation and acting as a positive allosteric modulator of the human CB1 (hCB1) receptor |
|
| DCC4508 | Rti-97 | Novel potent and selective KOR antagonist |
|
| DCC4509 | Rtiox-372 | Novel Potent and Selective Orexin-1 Receptor Antagonist |
|
